Fair Value Calculator Fair Value Calculator
EN DE

Radix Industries (India) Limited (531412) Fair Value & Analysis

Other · IN · Market cap ₹936M

RI Radix Industries (India) Limited 531412 · BSE
Price₹165.65
Fair Value₹96.14
Upside-42.0%
Quality59/100
Watch Radix Industries (India) Limited for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹72.10 – ₹120.17

Fair value as of: Jul 4, 2026

From 24 valuation models · updated today

Share price −11.9% over the past month.

Price vs Fair Value (12 months)

₹215.65 ₹153.65 Fair Value ₹96.14 Jul 2025 Jul 2026

12‑month range ₹153.65 – ₹215.65 · fair‑value band ₹72.10 – ₹120.17 · the ₹165.65 price screens above the ₹96.14 fair value. As of Jul 4, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Radix Industries (India) Limited (531412) currently trades at ₹165.65, while our model-based Fair Value estimate is ₹96.14 — implying the stock looks roughly 42.0% overvalued today. We read business quality at 59/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Net debt stands at ₹3.5M. The stock trades on a trailing P/E of 78.9. Fundamentals as of Jul 4, 2026

Key figures & financial health

Free cash flow ₹65.6M FY2026
P/E ratio 78.9
EPS (TTM) ₹0.7913
Net debt ₹3.5M FY2024

Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.

About the company

Radix Industries (India) Limited manufactures and sells human hair products in India and internationally. The company was incorporated in 1993 and is based in Tanuku, India.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Radix Industries (India) Limited reported revenue of ₹505M in FY2026 versus ₹254M in FY2022, a compound +18.7%/yr. Reported net income was ₹32.0M in FY2026, compounding +20.7%/yr from FY2022.

Revenue +18.7%/yr
FY22 ₹254M
FY23 ₹263M
FY24 ₹330M
FY25 ₹483M
FY26 ₹505M
Net income +20.7%/yr
FY22 ₹15.1M
FY23 ₹15.3M
FY24 ₹22.3M
FY25 ₹26.3M
FY26 ₹32.0M

Is 531412 fairly valued? → Check now

Similar stocks

6 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).

Stock Price Fair Value vs Fair Value
There MOH €521.90 €269.92 -48%
Sony Corporation SON1 €17.58 €37.56 +114%
Federal Home Loan Mortgage Corporation FREJO $16.84 $64.93 +286%
533278 533278 ₹438.60 ₹720.31 +64%
Nestl?? India Limited 500790 ₹1,459 ₹279.60 -81%
540376 540376 ₹3,993 ₹1,806 -55%

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Radix Industries (India) Limited (531412) undervalued?
As of Jul 4, 2026, our model estimates a fair value of ₹96.14 versus a price of ₹165.65 — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 531412?
Our model-based fair value for Radix Industries (India) Limited is ₹96.14 (as of Jul 4, 2026), built from audited fundamentals. The current price is ₹165.65.
What is the quality score of 531412?
Radix Industries (India) Limited has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of 531412?
The net profit margin of Radix Industries (India) Limited is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.